Validation of the 4B5 rabbit monoclonal antibody in determining Her2/neu status in breast cancer
- 1 July 2009
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 22 (7) , 879-886
- https://doi.org/10.1038/modpathol.2009.37
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Cardiac Toxicity in Breast Cancer Survivors: Review of Potential Cardiac ProblemsClinical Cancer Research, 2008
- Immunohistochemical Antibodies in Breast Cancer HER2 DiagnosticsTumor Biology, 2008
- Chromogenic in situ hybridisation for the assessment of HER2 status in breast cancer: an international validation ring studyBreast Cancer Research, 2007
- HER2 evaluation using the novel rabbit monoclonal antibody SP3 and CISH in tissue microarrays of invasive breast carcinomasJournal of Clinical Pathology, 2006
- Determination of HER2 Gene Amplification by Fluorescence In situ Hybridization and Concordance with the Clinical Trials Immunohistochemical Assay in Women with Metastatic Breast Cancer Evaluated for Treatment with TrastuzumabBreast Cancer Research and Treatment, 2005
- Rabbit Monoclonal AntibodiesAmerican Journal of Clinical Pathology, 2005
- Rabbit Monoclonal Antibodies: A Comparative Study Between a Novel Category of Immunoreagents and the Corresponding Mouse Monoclonal AntibodiesAmerican Journal of Clinical Pathology, 2005
- HER-2/neu assessment in breast cancer by immunohistochemistry and fluorescence in situ hybridization: Comparison of results and correlation with survivalMolecular Diagnosis, 2000
- HER-2/neu Assessment in Breast Cancer by Immunohistochemistry and Fluorescence In Situ Hybridization: Comparison of Results and Correlation With SurvivalMolecular Diagnosis, 2000
- Tissue microarrays for high-throughput molecular profiling of tumor specimensNature Medicine, 1998